Literature DB >> 20229499

Development and application of a multiplexable flow cytometry-based assay to quantify cell-mediated cytolysis.

Lan-Feng Cao1, Ludmila Krymskaya, Vivi Tran, Shu Mi, Michael C Jensen, Suzette Blanchard, Michael Kalos.   

Abstract

Although target cell cytolysis has been widely employed to describe effector function of cells, cytolysis assays as commonly employed do not generate quantitative data. In this report we describe the development and application of a statistically supported flow cytometry-based assay to quantify cell-mediated cytolysis. The assay depends on the use of the fluorescent dye CFSE to distinguish target from effector cells, the DNA intercalating dye 7AAD to distinguish dead from live cell events, and on the establishment of a cytolysis curve that allows for the derivation of statistically robust data. We demonstrate that the cytolysis curve is well described by a four parameter logistic regression model provided that (i) the range of effector to target (E:T) ratios studied allows for full description of the logistic curve, and (ii) an adequate number of data points are collected to estimate the model parameters. We show that the assay is highly reproducible and accurate, and comparable in sensitivity with the standard (51)Cr assay. We report on the potential for this assay to generate quantitative data on the cytolytic activity of both CD8 T and NK cells; describe a relationship between the efficiency of effector cell degranulation and target cell cytolysis throughout a range of E:T ratios, and demonstrate the potential to multiplex with other platforms to obtain broader datasets for the effector phenotype of cells. Appropriate use of this assay will enhance the ability to derive quantitative and integrated correlative datasets from basic, translational, and clinical studies. Copyright 2010 International Society for Advancement of Cytometry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20229499     DOI: 10.1002/cyto.a.20887

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  9 in total

1.  Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor.

Authors:  Yangbing Zhao; Edmund Moon; Carmine Carpenito; Chrystal M Paulos; Xiaojun Liu; Andrea L Brennan; Anne Chew; Richard G Carroll; John Scholler; Bruce L Levine; Steven M Albelda; Carl H June
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

2.  CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia.

Authors:  S S Kenderian; M Ruella; O Shestova; M Klichinsky; V Aikawa; J J D Morrissette; J Scholler; D Song; D L Porter; M Carroll; C H June; S Gill
Journal:  Leukemia       Date:  2015-02-27       Impact factor: 11.528

3.  CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients.

Authors:  Andrew J Rech; Rosemarie Mick; Sunil Martin; Adri Recio; Nicole A Aqui; Daniel J Powell; Theresa A Colligon; Jennifer A Trosko; Leah I Leinbach; Charles H Pletcher; Carol K Tweed; Angela DeMichele; Kevin R Fox; Susan M Domchek; James L Riley; Robert H Vonderheide
Journal:  Sci Transl Med       Date:  2012-05-16       Impact factor: 17.956

4.  Enhanced function of redirected human T cells expressing linker for activation of T cells that is resistant to ubiquitylation.

Authors:  Naoki Kunii; Yangbing Zhao; Shuguang Jiang; Xiaojun Liu; John Scholler; Lakshmi Balagopalan; Lawrence E Samelson; Michael C Milone; Carl H June
Journal:  Hum Gene Ther       Date:  2012-11-06       Impact factor: 5.695

5.  QPY/RAH haplotypes of the GZMB gene are associated with natural killer cell cytotoxicity.

Authors:  Wataru Oboshi; Toru Watanabe; Keisuke Hayashi; Takehiro Nakamura; Nobuyasu Yukimasa
Journal:  Immunogenetics       Date:  2017-06-26       Impact factor: 2.846

Review 6.  Genetic defects in cytolysis in macrophage activation syndrome.

Authors:  Mingce Zhang; Edward M Behrens; T Prescott Atkinson; Bita Shakoory; Alexei A Grom; Randy Q Cron
Journal:  Curr Rheumatol Rep       Date:  2014       Impact factor: 4.592

7.  Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells.

Authors:  Saar Gill; Sarah K Tasian; Marco Ruella; Olga Shestova; Yong Li; David L Porter; Martin Carroll; Gwenn Danet-Desnoyers; John Scholler; Stephan A Grupp; Carl H June; Michael Kalos
Journal:  Blood       Date:  2014-03-04       Impact factor: 22.113

8.  Effect of Methionine Restriction on Bone Density and NK Cell Activity.

Authors:  Mingxin Li; Lidong Zhai; Wanfu Wei; Jingming Dong
Journal:  Biomed Res Int       Date:  2016-11-02       Impact factor: 3.411

9.  An altered cytotoxic program of CD8+ T-cells in HIV-infected patients despite HAART-induced viral suppression.

Authors:  Federico Perdomo-Celis; Paula A Velilla; Natalia A Taborda; María Teresa Rugeles
Journal:  PLoS One       Date:  2019-01-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.